Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02500628 · ClinicalTrials.gov registry record · Phase 2
Heart Rate Variability in Response to Metformin Challenge
A Phase 2 study of Diabetes Mellitus, Type 2 and Fibromyalgia, sponsored by Woodinville Psychiatric Associates.
- Completed
- Registry status
- Phase 2
- Development phase
- 61
- Enrollment target
- 1
- Study location
NCT02500628 is a Phase 2 study of Diabetes Mellitus, Type 2 and Fibromyalgia that has completed, run by Woodinville Psychiatric Associates. The registered enrollment target is 61 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02500628, a Phase 2 study of Diabetes Mellitus, Type 2 and Fibromyalgia, has completed, sponsored by Woodinville Psychiatric Associates.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
Diseases caused by brain energy supply defects can be innate (fibromyalgia secondary to familial mitochondrial disorders) or acquired (tardive dyskinesia or weight gain associated with prolonged antipsychotic use). Patients with these possible mitochondrial disorders will provide a baseline resting heart rate sample, ingest low-dose metformin (500 mg), and then provide an additional sample 2 hours later.
Conditions Studied
Interventions
- DRUG Metformin
Study Locations (1)
Washington
- Woodinville Psychiatric Associates - Woodinville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02500628
The ClinicalTrials.gov registry entry for NCT02500628 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The listed sponsor is Woodinville Psychiatric Associates, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Metformin is the first listed.
NCT02500628 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT02500628 about?
NCT02500628 is a clinical study titled "Heart Rate Variability in Response to Metformin Challenge". Diseases caused by brain energy supply defects can be innate (fibromyalgia secondary to familial mitochondrial disorders) or acquired (tardive dyskinesia or weight gain associated with prolonged antipsychotic use). Patients with these possible mitochondrial disorders will provide a baseline resting ...
What is the current status of trial NCT02500628?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 61 participants. The study started on 2015-07. Estimated completion is 2016-02.
What conditions does trial NCT02500628 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Fibromyalgia, Movement Disorders, Mitochondrial Diseases.
What interventions are being tested in trial NCT02500628?
The interventions under investigation include: Metformin (DRUG).
Who is sponsoring clinical trial NCT02500628?
This trial is sponsored by Woodinville Psychiatric Associates, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02500628 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DETERMINE: Detemir vs NPH
RECRUITING · Phase 2
-
MANAGe-DM: Novel Nurse Case Management to Improve Diabetes Outcomes in Formerly Incarcerated Black Men
RECRUITING · Phase 2
-
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
RECRUITING · Phase 2
-
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
RECRUITING · Phase 2
-
A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy
ACTIVE NOT RECRUITING · Phase 2
-
Addressing Basic Needs to Improve Diabetes Outcomes in Medicaid Beneficiaries
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.